Targeting DNA Repair Defects in Prostate Cancer: The Role of PARP Inhibitors

Get up to date on the use of newly approved and emerging PARP inhibitors for the treatment of patients with metastatic CRPC and DNA repair defects. Includes a case study!
Celestia Higano Headshot
Celestia S. Higano, MD, FACP
Charles J. Ryan, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 744 KB
Released: July 9, 2020

Acknowledgements

Provided by Clinical Care Options, LLC.

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Pfizer Inc.

Related Content

From ASCO 2020: analysis by Daniel P. Petrylak, MD, and Elizabeth R. Plimack, MD, MS, of key studies in renal cell carcinoma, urothelial carcinoma, and prostate cancer from CCO

Daniel P. Petrylak, MD Elizabeth R. Plimack, MD, MS Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: September 1, 2020 Expired: August 31, 2021

From Clinical Care Options (CCO), an on-demand Webcast on immuno-oncology biomarkers that are key to optimal cancer treatment across multiple tumors

John L. Marshall, MD
Program Director
Jamie E. Chaft, MD Scot Niglio, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: August 24, 2020 Expired: August 23, 2021

From Clinical Care Options (CCO), watch video of an expert discussion of NTRK fusion testing and TRK inhibitor use in solid cancers

George D. Demetri, MD
Program Director
person default Alexander Drilon, MD Pashtoon Kasi, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: August 21, 2020 Expired: August 20, 2021

From Clinical Care Options (CCO), video featuring expert presentations on the role of PARP inhibition in the treatment of prostate cancer

Celestia Higano Headshot Celestia S. Higano, MD, FACP
Program Director
Charles J. Ryan, MD
Physicians: maximum of 1.25 AMA PRA Category 1 Credits Released: August 10, 2020 Expired: August 9, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?